Skip to main content
Reimbursement strategy

Market Access Strategy for Medical Devices in Europe

Strategic recommendations on the topic of market access pathways for medical devices and IVD tests

Learn more

White Paper: Evidence requirements for LPPR List process in France, part 1

Get insights from MTRC White Papers to enhance your understanding of the analysis of five HTAs and strategic recommendations for evidence generation strategy in France

Request free of charge

White Paper: Evidence requirements for LPPR List process in France, part 2

Get insights from MTRC White Papers to discover five recent HAS reports with negative recommendations (March 2024)

Request free of charge
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

October 2025 recommendations about add-on reimbursement for medical devices in France